Unibest

Pharmaceutical intermediates

Sunitinib Malate Intermediates

2 pharmaceutical intermediates for Sunitinib Malate. Indication: Pancreatic neuroendocrine tumors; Renal cell carcinoma; Gastrointestinal stromal tumor.

提交项目All intermediates

About Sunitinib Malate

Originator
Pfizer Inc
Indication
Pancreatic neuroendocrine tumors; Renal cell carcinoma; Gastrointestinal stromal tumor
Approved Date
03/31/2009

Available intermediates

2 intermediates currently listed for Sunitinib Malate. Request specifications, documentation or a quotation for any item below.

Sunitinib Malate intermediates
Product NameCAS No.Molecular FormulaPhysical Properties
5-Fluoro-2-oxindole56341-41-4//
5-Formyl-2,4-dimethyl-1H-pyrrole-3-carboxylic acid253870-02-9//

Other programs under S

SaracatinibSarecycline HydrochlorideSarolanerSaxagliptinSeladelparSeltorexantSemaglutideSitafloxacin hydrate

Building toward Sunitinib Malate?

Tell us the step you need covered and the specification you are filing against. We will confirm supply, documentation and lead time.

提交项目 联系团队

我们能如何帮助您？

获取最新活动与法规动态洞察

直接发送到您的邮箱

在此获取行业洞察与 Unibest 动态

联系我们 →